title: Increased vulnerability of neurones and glial cells to low concentrations of methylmercury in a prooxidant situation.
abstract: Using reaggregating rat brain cell cultures at two different stages of differentiation, we examined the biochemical effects of a 10-day treatment with nanomolar concentrations of methylmercuric chloride (monomethylmercury), in the presence or absence of promoters of hydroxyl radical formation (10 microM copper sulphate plus 100 microM ascorbate). A decrease in total protein content accounted for the general cytotoxicity of these compounds, whereas selective effects were assessed by determining the activities of cell type-specific enzymes. Methylmercury, up to 100 nM, as well as the copper ascorbate mixture, when applied separately, induced no general cytotoxicity, and only slight effects on neuronal parameters. However, when applying 100 nM methylmercury and the copper-ascorbate mixture together, a drastic decrease in neuronal and glial parameters was found. Under these conditions, the content of reactive oxygen species, assessed by 2',7'-dichlorofluorescin oxidation, increased greatly, while the activities of antioxidant enzymes decreased. In the presence of copper and ascorbate, differentiated cultures appeared more resistant than immature ones to low methylmercury concentrations (1-10 mM), but did undergo similar changes in both cell type-specific and antioxidant enzyme activities at 100 nM methylmercury. These results suggest that in prooxidant conditions low doses of mercury can become much more deleterious for the central nervous system.
authors.affiliation: Institute of Physiology, Lausanne, Switzerland.
authors.forename: O
authors.initials: O
authors.lastname: Sorg
authors.forename: B
authors.initials: B
authors.lastname: Schilter
authors.forename: P
authors.initials: P
authors.lastname: Honegger
authors.forename: F
authors.initials: F
authors.lastname: Monnet-Tschudi
mesh_terms: D000818:Animals; D001205:Ascorbic Acid / Q000494:pharmacology; D001921:Brain / Q000166:cytology; D002478:Cells, Cultured; D019327:Copper Sulfate / Q000494:pharmacology; D004338:Drug Combinations; D004351:Drug Resistance; D005452:Fluoresceins; D017665:Hydroxyl Radical / Q000819:agonists*; D008767:Methylmercury Compounds / Q000494:pharmacology*; D009457:Neuroglia / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D009474:Neurons / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D009994:Osmolar Concentration; D051381:Rats / Q000196:embryology; D017382:Reactive Oxygen Species / Q000378:metabolism
chemical_list: D004338:Drug Combinations; D005452:Fluoresceins; D008767:Methylmercury Compounds; D017382:Reactive Oxygen Species; D017665:Hydroxyl Radical; C037631:2',7'-dichlorofluorescein; D019327:Copper Sulfate; D001205:Ascorbic Acid